Earkart Ltd. · BSE:EARKART
Earkart — Investor Presentation (June 2026)
23 slides from Earkart's investor presentation, Jun 27, 2026
Slide 1: BSE submission letter under Regulation 30
To Corporate Relationship Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Fort, Mumbai – 400 001 Maharashtra, India Scrip Name : Earkart Limited Scrip Code : 544549 ISIN : INE1A8F01035 Subject : Submission of Investor Presentation pursuant to Regulation 30 of the SEBI (Listing Obligat
Slide 2: Investor Presentation FY26
www.earkart.in Investor Presentation FY26
Slide 3: Disclaimer
Redefining Hearing Care Disclaimer This presentation (the “Presentation”) has been prepared by Earkart Ltd (“the Company”) solely for informational purposes. It does not constitute an offer, recommendation, or invitation to purchase or subscribe for any securities, and should not be relied upon in c
Slide 4: Company Overview
Redefining Hearing Care Company Overview Earkart Limited is an integrated hearing healthcare platform offering diagnostics, hearing aids, and technology-enabled hearing solutions across India. 4 Brands 61% Revenue From Government and Manufacturing & office Area EQFY, Fame, Radius, The company offers
Slide 5: Our Journey
Redefining Hearing Care Our Journey BIS license received Launch of ENT (Shop in Shop Model) Incorporated wholly-owned subsidiary Received First Government order for Launch of remote video Audiometry Earkart Inc. (USA) 10,000 Hearing Aids units Device OMNI Secured multiple ALIMCO government Conversio
Slide 6: Management Profile
Redefining Hearing Care Management Profile Mr. Rohit Misra Ms. Monika Misra Promoter & Managing Director Promoter & Whole- Time Director Experience: 30+ Years Experience: 25+ years Qualification: Holds B.Sc. (Meerut University) & Diploma in Holds B.Sc. (1993) & M.Sc. (1995) from Meerut Qualification
Slide 7: Manufacturing Facility
Redefining Hearing Care Manufacturing Facility Team & Technology Capabilities End-to-end production: MIC processing, receiver Dedicated team of 9+ skilled employees in R&D integration & BTE assembly Equipped with advanced manufacturing & testing In-house PCBA integration & testing machinery Comprehe
Slide 8: Certifications
Redefining Hearing Care Certifications Post Approval BIS Certified (Bureau of Indian File No : MD/PostAppr/2025/34163 Food And Drug Administration, Uttar Pradesh, Date: 30-May-2025 Standards) To M/s Earkart Pvt. Ltd., Shop No. 8-P, Street No. 6, Vasundhara Enclave Delhi, East Delhi, Delhi Certificat
Slide 9: Business Model
Business Model Shop-in-Shop (SIS) Model Offers a portfolio of own brands EQFY, Fame, Private Business Radius, and Tiny alongside third-party Sales are driven through an extensive accessories and rehabilitative products. network of retailers, wholesalers, and Operates 82 SIS clinics across ENT and op
Slide 10: Product Portfolio
Redefining Hearing Care Product Portfolio Brands: EQFY, Fame, Radius, Tiny BRANDS Range: Behind-the-Ear (BTE) and Receiver-in-Canal (RIC) models Features: Digital, programmable, rechargeable, and Bluetooth-enabled for seamless connectivity Positioning: Designed for affordability and accessibility, e
Slide 11: Industry Overview
Redefining Hearing Care Industry Overview The global hearing aid market, valued at $8.1B in 2023, is projected to grow at a 6.6% CAGR to reach $12.67B by 2030. About 430M people (~5% of the global population) need hearing rehabilitation, with 66.5% aged 60+, Key Growth Drivers 25.6% aged 15–59, and
Slide 12: OMNI 2.0 – World's 1st Full Stack Remote Hearing Diagnostic
OMNI 2.0 – World’s 1st Full Stack Redefining Hearing Care Remote Hearing Diagnostic Over 60% of India’s population, Traditional models require each especially in Tier 2/3 cities and patient to visit a local audiologist rural areas, have no access to —making access nearly audiology services. impossib
Slide 13: OMNI 2.0 – World's 1st Full Stack Remote Hearing Diagnostic
OMNI 2.0 – World’s 1st Full Stack Redefining Hearing Care Remote Hearing Diagnostic Overview This disrupts scarcity, bringing last-mile hearing care to unserved cities and towns, and has been met with overwhelming demand in India and internationally. Diagnostic Capabilities Remote-operated audiomete
Slide 14: Earkart Breaks New Ground with Patent Approval
Earkart Breaks New Ground with Patent Approval Earkart has been granted a patent for its “Smart Sound Treatment and Diagnosis System and Method Thereof” under The Patents Act, 1970, reinforcing its differentiated technology platform and strengthening its position in next-generation remote hearing di
Slide 15: Geographical Presence
Redefining Hearing Care Geographical Presence S.no State Name S.no State Name 1 Assam 12 Kerala 2 Bihar 13 Madhya Pradesh 3 Chandigarh 14 Maharashtra 4 Chhattisgarh 15 Mizoram 5 Delhi 16 Punjab 6 Gujarat 17 Rajasthan 7 Haryana 18 Tamil Nadu 8 Himachal Pradesh 19 Telangana 9 Jammu & Kashmir 20 Uttar
Slide 16: Future Growth & Expansion Plans
Future Growth & Expansion Plans Strategic & Inorganic Growth Pursue strategic partnerships and selective acquisitions to accelerate growth. Expand market presence through value-accretive inorganic opportunities. Diversify revenue streams and strengthen long-term value creation. Distribution Expansio
Slide 17: Revenue Bifurcation
Redefining Hearing Care Revenue Bifurcation (₹ in Lakhs) (₹ in Lakhs) 8.57% BY SEGMENT BY GEOGRAPHY 61.32% 5.84% 38.68% 3.01% 1.44% 1.44% 3.23% 76.47% Particulars FY 2025-26 % Particulars FY26 % Government 3313.38 61.32% Uttar Pradesh 4,132.13 76.47% Private 2090.15 38.68% Delhi 462.97 8.57% Total 5
Slide 18: Profit & Loss
Redefining Hearing Care Profit & Loss (₹ in Lakhs except EPS) Particulars H2FY26 H1FY26 HOH% FY26 FY25 YoY% Revenue from Operations 3174.96 2228.57 42.47% 5403.53 4310.62 25.35% Other Income 8.2 2.44 236.07% 10.65 8.59 23.98% Total Income 3183.16 2231.01 42.68% 5414.18 4319.21 25.35% Total Expenditu
Slide 19: Balance Sheet
Redefining Hearing Care Balance Sheet (₹ in Lakhs) Particulars As at March 31,2026 As at March 31,2025 Share Capital 1375.39 1043.89 Reserves 5059.13 936.71 Short Term Borrowings 0.24 495.93 Trade Payables 180.09 301.67 Other Liabilities 334.35 246.23 Total Liabilities 6949.20 3024.43 Fixed Assets 5
Slide 20: FY26 Performance & FY27 Growth Outlook
FY26 Performance & FY27 Growth Outlook Key Strategic Initiatives in FY26 Global Expansion & Corporate Strengthening Talent & Capability Enhancement Innovation & Technology Investments Incorporated Earkart Inc. (USA) as a wholly Strengthened teams across R&D, audiology, Increased focus on product inn
Slide 21: Earkart at World's Largest ENT Conference
Earkart at World’s Largest ENT Conference Global Event Presence Innovation & Engagement Earkart participated in the world’s largest otolaryngology Showcased OMNI, Earkart’s remote diagnostic platform, at conference in Indianapolis, USA, from October 11–13, 2025. the world’s largest ENT and audiology
Slide 22: Earkart at AOICON Kolkata 2026 Advancing Remote Audiology
Earkart at AOICON Kolkata 2026 Advancing Remote Audiology Global Event Presence Innovation & Engagement At AOICON Kolkata 2026, Earkart engaged with ENT During AOICON Kolkata 2026, Earkart showcased OMNI, its professionals, audiologists, and healthcare leaders from full-stack remote audiology and di
Slide 23: Thank You
THANK YOU Preeti Srivastava Abhishek Bhutra | Himanshu Jain Company Secretary +91 80006 85556 , +91 89051 81853 ir@earkart.in ir@finportalin.com Meeting Request & Investor Tool Kit Link